Worldwide, hepatitis B virus is the major risk factor for hepatocellular carcinoma (HCC), owing to ... surveillance regimes of α-fetoprotein and ultrasound may be augmented by novel biomarkers ...
Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.
A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of Michigan, shows that artificial intelligence (AI) can help doctors make better ...
More information: David Requena et al, Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma, Nature Communications (2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback